Shankland named CMPMedica CEO

Share this article:
CMPMedica named Sally Shankland CEO of CMPMedica US, replacing Vicki Masseria.

Shankland was previously SVP of the firm's US promotional business unit, a role she served for six years. She has worked for CMPMedica owner United Business Media since 1988, when she joined Miller Freeman. She orchestrated the 2006 launch of SearchMedica. Harry Elkington, global CEO of CMPMedica, praised her “great track record in building the promotional side of our business.”
Masseria spent 26 years with CMPMedica and its predecessor companies. Through a CMPMedica spokesperson, she declined comment on her future plans.

Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union